Mechanism and relevance of active DNA methylation during monocyte differentiation

单核细胞分化过程中活跃DNA甲基化的机制和相关性

• 批准号: 278631977
• 负责人: Professor Dr. Michael Rehli
• 金额: --
• 依托单位: Klinik und Poliklinik für Innere Medizin III
• 依托单位国家: 德国
• 项目类别: Research Grants
• 财政年份: 2015
• 资助国家: 德国
• 起止时间: 2014-12-31 至 2019-12-31
• 项目状态: 已结题
• 来源: https://gepris.dfg.de/gepris/projekt/278631977?language=en
• 关键词: Mechanism; relevance; active; DNA; methylation

Experimental evidence as well as the high frequency of mutations in TET2 and IDH genes in acute myeloid leukaemia suggests that DNA methylation turnover is essential for normal myelopoiesis. Previous work from others as well as work from our lab suggests a major role for transcription factors in targeting DNA demethylation to lineage-specific enhancers. However, in the large majority of cases it is not actually clear whether the observed demethylation is 'just' the consequence of transcription factor binding, chromatin remodelling and e.g. enhancer activation, or whether it is required for the latter. To understand the relevance and function of DNA demethylation both in normal myeloid cells as well during leukaemogenesis we need to understand better and define, which sequence features and which factors require demethylation to establish stable transcription factor -DNA interactions and to participate in gene regulatory processes. In the current application we propose to study the differentiation of post-mitotic monocytes to address remaining key questions related to the mechanisms of active DNA demethylation. Using a recently established, highly efficient and non-toxic/activating siRNA transfection protocol we will knock-down the expression of key genes (including TET2 as well as candidate targeting transcription factors) and study the effect on transcription, DNA methylation, chromatin accessibility, histone modifications and transcription factor binding. This will ultimately clarify the functional importance of DNA demethylation, and how it is targeted in myeloid cells. The findings will not only be important for the general understanding of monocyte biology but also for our understanding how mutations in the DNA methylation machinery might alter hematopoietic cells to drive leukaemogenesis.

实验证据以及急性髓系白血病中 TET2 和 IDH 基因的高频率突变表明 DNA 甲基化更新对于正常骨髓细胞生成至关重要。其他人之前的工作以及我们实验室的工作表明转录因子在将 DNA 去甲基化靶向谱系特异性增强子方面发挥着重要作用。然而，在大多数情况下，实际上并不清楚观察到的去甲基化是否“仅仅是”转录因子结合、染色质重塑等的结果。增强子激活，或者后者是否需要。为了了解DNA去甲基化在正常骨髓细胞以及白血病发生过程中的相关性和功能，我们需要更好地了解和定义哪些序列特征和哪些因素需要去甲基化以建立稳定的转录因子-DNA相互作用并参与基因调控过程。在当前的应用中，我们建议研究有丝分裂后单核细胞的分化，以解决与主动 DNA 去甲基化机制相关的剩余关键问题。使用最近建立的高效且无毒/激活的 siRNA 转染方案，我们将敲低关键基因（包括 TET2 以及候选靶向转录因子）的表达，并研究其对转录、DNA 甲基化、染色质可及性、组蛋白修饰和转录因子结合的影响。这将最终阐明 DNA 去甲基化的功能重要性，以及它如何在骨髓细胞中发挥作用。这些发现不仅对于单核细胞生物学的一般理解很重要，而且对于我们理解 DNA 甲基化机制的突变如何改变造血细胞以驱动白血病发生也很重要。